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INTRODUCTION. 
The results of the use of drugs of the sulphonamide 
group in the treatment of bacillary dysentery have bee 
extensively studied both in this country and in the 
11United States; they have also been studied in the 
treatment of the disease in the forces in the Middle 
mast and other theatres of war. 
There are many factors which make it difficult 
to interpret the results of the use of any drug in the 
treatment of bacillary dysentery in Great Britain. 
irst of all the disease, as seen in this country, is 
typically a very mild ones although cases of all grade 
of severity are encountered. Usually the illness lasts 
for only a few days, diarrhoea with loose stools con- 
taining, blood and mucus being the main symptom; but 
there are many cases which are só mild that only a few 
loose stools are passed, and there is the odd very 
severe case endangering life itself. It will therefor 
be difficult to demonstrate the effect of drugs in the 
very mild cases, as they will almost have recovered 
before any drug could take effect, and the presence of 
a large number of such cases in any series will mask 
the effect of the drug on the more severe cases; also 
it will be necessary to draw definite conclusions only 
from strictly controlled series of cases in any given 
outbreak, as by that means alone can allowance be made 
for/ 
2. 
for the effect of varying severity of the disease in 
different epidemics. Further, it will be necessary to 
have a sufficiently large number of cases for study, 
so that there would be a chance of observing cases of 11 
grades of severity. Then the different bacteriologica 
types of dysentery bacilli respond differently to 
sulphonamide treatment so that, if the results of 
treatment are to be of real value, all cases studied 
must be examined bacteriologically. 
The efficacy of the drugs in preventing the occur- 
rence of, or reducing the number of convalescent 
carriers, and in rendering persistent carriers bacterio- 
logically negative is of as much importance as, indeed 
is, in many cases, of more importance than, its effect 
on the clinical course of the disease. This can only 
be studied if adequate clearance tests are used, and 
if the cases are kept under observation for a sufficient 
length of time after treatment, so that the intermittent 
carrier will be detected, and also the case which re- 
lapses bacteriologically some time after treatment has 
been stopped. For this purpose it will also be neces- 
sary to see that chances of re- infection are reduced 
to a minimum and, once again, controls are really 
necessary as the convalescent carrier rate varies with 
different types of organism, in different epidemics 
and with the age -group to which the patients belong. 
The/ 
3. 
The clinical features of the disease as seen in 
the United States, at least around New York, have been 
described recently by Hardy and Watt (1944) in a revie 
of 1,500 cases. It would appear that the vast majorit 
of the cases there are similar in severity to those in 
this country. They suggest the name "Shigéllosis" for 
the disease as a great many of the cases never suffer 
from "dysentery" which, strictly speaking, means "bloo 
and mucus in the stools ". Nevertheless, many of the 
cases described in American literature are of a severit 
rarely seen in this country. 
Manson -Bahr (1942) also points out that many cases 
of infection with dysentery bacilli never have blood 
and mucus in the stools even in countries where the 
disease is often vary severe. The published work on 
the treatment with sulphonamides of bacillary dysentery 
in the forces contains many.accounts of very severe 
cases, but also, in some the disease was very similar 
to that seen in this country. Scadding (1945), in, 
particular, describes treatment in an outbreak of 
relatively mild cases in the forces, and emphasises 
the difficulties of assessing the results of treatment 
in such cases. 
In Part I. of this thesis some of the literature 
recording the results of treatment of bacillary 
dysentery with sulphonamides is summarised and the 




In Part II. the results of the treatment of 1000 
cases with salts, sulphaguanidine or succinyl suipha- 
thiazole at the City Hospital, Edinburgh are recorded 
and discussed, together with the results of blood 
sulphaguanidine and succinyl sulphathiazole estimations 
carried out on some of the cases. All of these cases 
were examined and observed by me while I was Senior 
Assistant at the hospital. 
The results obtained by myself together with those 
of others are discussed in Part III. and recommenda- 
tions for the chemotherapy of the disease as seen in 
this country are made. 
5. 
PART I. 
WORK .JON2 IN BRITAIN. 
In great Britain Anderson and Cruickshank (1941) 
described the results of treatment of 41 cases of 
bacillary dysentery with sulphaguanidine, and compared 
them with 55 cases occurring in the same epidemic 
which had no specific treatment; from 59 of the cases 
studied the klexner (z and x) dysentery bacillus was 
isolated; the dosage of the drug used was at first 
gm II t.i.d. for 4 days followed by gm III daily for 
2 days but, as the drug was very well tolerated, the 
dose was increased to gm IV daily for up to a week if 
necessary. The clinical results were good when com- 
pared with the controls and, out of 16 treated cases 
examined bacteriologically after treatment, three were 
positive but two became negative after a further week 
of the drug; while, out of 17 control cases similarly 
examined, 8 were positive after the first week, 5 in 
the third week, 2 in the fourth and one in the sixth 
week. It will be seen that the dosage of drug used 
here is small compared with later series and the con- 
trols were not treated at exactly the same time as the 
other cases studied, but still the sulphaguanidine 
appears to have given superior clinical results, and to 
have reduced the number of convalescent carriers. 
The patients were all adults and the specimens for 
bacteriological / 
6. 
bacteriological examination were taken from the rectum 
with a loop and grown on a desoxycholate- citrate medium; 
but all the cases were not confirmed bacteriologically. 
Clay (1943) compared the results of treatment with 
sulphaguanidine, sulphanilamide and salts in 273 cases 
of bacillary dysentery, 151 being Flexner infections 
and 122 bonne infections; sulphaguanidine was given in 
doses of 0.5 gm. per kilo in the first 24 hrs followed 
by 0.1 gm. per kilo given in three doses for 4 days; 
sulphanilamide was given in doses of gm I 4 hrly for 
4 days and then gm. I t.i.d. for 4 days; the salts 
treatment consisted of >II of sodium sulphate twice 
a day; the standard of clearance used was 3 consecutive 
negative stools taken at twice weekly intervals. The 
stay in hospital and the number of days during which 
the stools remained positive were reduced by half in 
the sulphaguanidine - treated cases as compared with 
those receiving no chemotherapy, except in the case of 
Sonne convalescent carriers; in the sulphanilamide - 
treated cases both the stay in hospital and the length 
of time during which stools remained positive were 
increased. The effect of sulphaguanidine in reducing 
the convalescent carrier rate, especially in Flexner 
infections, was marked in this series of cases. 
Swyer (1943) got good results both as regards clinical 
effect and bacteriological clearance with the use of 
sulphapyridine in 57 Sonne cases, when he compared them 
with/ 
7. 
with 35 controls; none of the sulphapyridine- treated 
cases relapsed bacteriologically while six bacteriologi al 
relapses occurred in the control series in from 7 to 36 
days. Jamieson et alia (1944) studied the results of 
treating 200 cases of bacillary dysentery comprising 
Flexner (73) Newcastle (78), Sonne (39) and mixed 
infections (10). 100 cases got sulphaguanidine,30 gms 
on the first day and then 8 gms. a day for 4 days; 
50 cases were treated with a chalk mixture; and 50 
cases with aperients, castor oil followed by milk of 
magnesia for children, who made up the bulk of the 
cases, and sodium sulphate for adults; the standard of 
clearance used was 3 consecutive negativo stools at 
twice weekly intervals, the first specimen being taken 
4-6 days after clinical cure. They considered that 
sulphaguanidine gave the best results so far as clinic 1 
cure was concerned, and the percentage of cases 
positive after treatment was reduced from 50% in the 
cases treated with salts and chalk to 30% in those 
receiving sulphaguanidine. Although the numbers of 
cases of the different bacteriological types of 
dysentery receiving each form of treatment are small 
in this series, the results taken as a whole are 
sufficiently striking. Another experiment carried out 
in this country where controls were used was that of 
Vollum and Wylie (1946) who treated an outbreak of 
Sonne dysentery in two boy's schools with succinyl- 
sulphathiazole,/ 
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succinyl- sulphathiazole, in six daily doses of 1 gm. 
for 5 days. They first treated 10 cases which were 
not isolated and found that 8 out of the ten were 
bacteriologically positive again in 4 weeks. They then 
treated all of the 37 cases in one school and left the 
33 cases in the other school untreated as controls; 
36 out of the 37 treated cases were negative after 
treatment while 11 out of the 33 controls continued to 
excrete the organism. They considered that re- infectio 
was the factor in the poor results in the first 10 
cases, and that succinyl sulphathiozole is the best 
available drug for treating Sonne infections. Several 
other British workers have published the results of 
treating, bacillary dysentery with various sulphonamide 
drugs without the use of controls. Masefield (1941) 
treated 16 moderately severe adult cases of Flexner 
dysentery with sulphapyridine, giving a total dosage 
of 13.5 gms. in 5 days. He found they were all 
bacteriologically negative by the 5th day using 4 
consecutive negative rectal swabs as the standard of 
clearance; and he and his staff considered that the 
illness was shortened by 7 days when compared with 
previous outbreaks in the same mental hospital. While, 
of course, it is possible that this was a milder type 
of/ 
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of dysentery, the results suggest that the sulphapyri- 
dine had a beneficial clinical effect, and also that 
it resulted in early bacteriological clearance. 
Smith (1944) records an interesting, experiment with 
the dosage of sulphaguanidine in 10 Flexner cases and 
34 carriers occurring in adult women. He gave a 
total dosage of 142 gms. in 10 days, 24 gms. being 
given daily for the first 3 days. The results of 
treatment were very satisfactory, all of the cases 
being bacteriologically negative at the end of the 
course as judged by the getting of 3 negative rectal 
swabs and 2 negative stool specimens over a period of 
14 days after treatment; but 21 toxic rashes developed 
about the 9th day of treatment. He found that eight 
out of twelve of those patients reacted to a sensitisa- 
tion dose of sulphagpanidine although there was no 
response to sensitisation doses of other sulphonamides. 
He suggests that the guanidine radical may be the 
sensitizing agent. It is interesting to note that, 
with this dosage of sulphaguanidine, blood levels of 
8 mgms. per 100 c.c. were got at first, and that the 
blood level fell to under 2 mgms. per 100 c.c. as the 
dose of the drug was reduced. Swyer (1943) compared 
the results of treatment in Sonne dysentery with three 
sulphonamide drugs, sulphanilylbenzamide, sulphanilyl- 
amidobenzamide and succinyl sulphathiazole. He treated 
179 cases in all, 41 with the first drug mentioned 
Bove 1l2 with the second and 26 with the third; the 
10. 
dosage was the same for all drugs and was according to 
the weight of the patient an adult getting 20 gms. in 
the first 24 hrs. and then 6 gms. a day for 4 days; 
all the patients were observed in hospital for a perio 
ranging from 4.5 days to 9 days before treatment was 
begun and, after treatment, they were observed for a 
period of 10.9 to 14.8 days; in the first series daily 
specimens of faeces and rectal swabs were examined and 
in the second and third series similar examinations 
were carried out on alternate days during all three 
periods. In the first series the stools were very 
markedly improved in 24 -48 hrs., in the second series 
they were also markedly improved by that time, but 
no great improvement in stools was noted in the third 
series. Bacteriological clearance was obtained in the 
first series in an average of 1.8 days, in the second 
series in 3.6 days for those cases which got full 
dosage of the drug, and in 2.5 days for some of the 
cases which only got half dosage, while in the third 
series the time for bacteriological clearance was 2.4 
days. Gases which relapsed bacteriologically, by which 
was meant cases giving a positive rectal swab after 
two consecutive negative ones, are not included in the 
above results. There were 3 such cases (7.3% ) in 
the first series, 11 (13.4% ) in the cases of the seco d 
series which got full doses and 1 (3.3% ) in the cases 
of/ 
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of the second series which got half doses, and 9 
(34.6% ) in the third series. Swyer points out that 
the efficacy of the drugs, particularly in clearing 
up carriers, was in direct proportion to the degree of 
absorption of drug from the intestine. The number of 
cases treated with succinyl sulphathiazole, however, is 
small compared with the other series, the dose, namely 
44 gms in 5 days is also small for this drug and the 
high proportion of bacteriological relapses in this 
group may be due to the presence of the drug in the 
faeces affecting the isolation of the organism, as 
specimens were taken all through the course of treatment. 
This factor would not operate so markedly with the 
other drugs which were absorbed to a greater extent. 
Phthalyl- sulphathiazole, in doses of 15 gms. on the 
first day followed by 4 gms a day for 4 days, was used 
by Brodie et alia (1946) in the treatment of 48 
bacteriologically proved cases of Sonne dysentery and 
40 clinical cases; 60 of the cases were under 10 years 
of age; the Sonne cases were cured clinically in 8.73 
days and 20.8% were positive in convalescence; the 
standard of clearance was 3 bi- weekly negative specimen: 
got 4 days after the drug had been stopped. Caldwell 
and Hardwick (1943) published the case of a woman of 
36 who was a persistent carrier of Flexner dysentery 
for 18 mths., in spite of four courses of sulphaguanidine, 
the/ 
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the first consisting of 9 gms a day for a month, and 
the others of 60 gms in 7 days; after that 9 gms of 
succinyl sulphathiazole were given for 7 days after 
which no further positive specimens were got. Although 
no definite conclusions can be drawn from one case 
which may have simply cleared up spontaneously after 
18 mths, it does look as if succinyl sulphathiazole 
was beneficial here where sulphaguanidine had failed. 
CONCLUSIONS MROM THE BRITISH WORK. 
It will be seen that all those British workers who 
treated bacillary dysentery with sulphonamide drugs, 
and who treated a control series of cases with salts 
or a chalk mixture for comparison, were of the opinion 
that the sulphonamides gave results superior to the 
other methods both as regards clinical effect and 
bacteriological clearance. Sulphaguanidine gave 
better results in blexner than in Sonne infections 
especially so far as bacteriological clearance was 
concerned; but sulphapyridine and succinyl sulpha- 
thiazole gave good results in Sonne infections. The 
series of cases treated without controls showed that 
sulphapyridine gave good results in Blexner infections, 
that phthalyl sulphathiazole probably gave better 
results in Sonne infections so far as bacteriological 
clearance was concerned than sulphaguanidine, and 
that/ 
13. 
that sulphanilylbenzamide and sulphanilylamidobenzamide 
also gave good results in Sonne infections. But in all 
those series, there were cases which were not bacterio- 
logically negative after several courses of the drugs 
and in no case did any particular drug render all cases 
bacteriologically negative if a sufficiently large 
number of cases was studied. 
14. 
WORK DONE IN AMERICA. 
During the same period, that is from 1941 onwards 
the treatment of bacillary dysentery with the sulphon- 
amides was being studied in the United States, and 
American literature provides several accounts of the 
results of that work. Lyon (1941) found that he got 
clinical improvement compared with controls when he 
treated 23 "severe or very severe" cases with sulpha - 
guanidine and used 23 similar cases as controls; half 
of the cases were proved bacteriologically but he did 
not study the bacteriological effects of treatment. 
Hardy et alia (1942) got good results when they treated 
57 Flexner and Newcastle casos and carriers with 
suiphaguanidine, but they had Eno carrier who still 
excreted the organism after 330 gms of the drug in 
22 days. Hall (1942) considered that good clinical 
results were got in a small series of 30 casos of 
Hiss infection in Kentucky. Most of the cases were 
children and the drug used was sulphaguanidine, half 
of the cases which were used as controls, receiving 
no specific treatment. Opper and Hale (1942) treated 
15 Flexner cases and 18 carriers with sulphaguanidin.e 
in the small dose of 4 gms daily for a week; all cases 
were bacteriologically negative at the end of the 
course, 4 relapsed but were cleared by a further course 
They compare those results with 18 cases and 20 carriers 
treated/ 
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treated in 1919 -40 without sulphaguanidine when 57% of 
the cases excreted the organism for over a month. This 
is, of course, not a strictly controlled series of 
cases, and the dose of the drug is very small. Smyth, 
Finkelstein et alia (1943) concluded that both sulpha - 
guanidine and succinyl sulphathiazole had some value 
in treating symptoms, from the treatment of 30 cases 
of Elexner dysentery, 10 with sulphaguanidine, 14 with 
succinyl sulphathiazole and 6 without specific treatment 
as controls. There were six deaths in the series, 4 
in the controls, 1 treated with sulphaguanidine and 
1 treated with succinyl sulphathiazole. So far as 
the use of sulphathiazole is concerned Rubens, Kaplan 
et alia (1943) thought that it was of definite value 
in the treatment of clinical dysentery in children, it 
reduced the number of days of diarrhoea from 8.8 to 
2.9; but Yannet and Leibovitz (1942) got poor results 
from its use in treating 44 Sonne cases and 13 carriers 
27 patients got sulphathiazole and the rest were used 
as controls, and the time taken for bacteriological 
clearance was longer in the drug- treated cases than 
in the controls. Roberts and Daniels (1943) found 
that succinyl sulphathiazole reduced the carrier rate 
from 18.2% to 2.6% in 225 cases of Boyd 88 infection, 
although it did not ameliorate or shorten the illness 
which was of about 4 days duration. The dose used 
was/ 
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was 0.25 gm per kilo as a first dose and then 0.25 gm. 
par kilo daily in six doses till the temperature had 
been normal for 2 days and diarrhoea had stopped for 
2 days and 89 cases got th3 drug, while 136 were used 
as controls. Phthalyl sulphathiazole was used in the 
treatment of 26 cases out of 59 Flexner, Schmitz and 
Sonne infections by Sandweiss (1944). He gave a dose 
of 0.1 gm. per kilo daily in 5 doses for an average of 
14 days and found that it had no effect on the carrier 
state, as 30% of the treated cases were still positive 
after treatment, and 56% of the treated cases observed 
for a longer period were positive for 8 -40 wks. com- 
pared with :3:3% of the controls. This is not as good a 
result, so far as bacteriological clearance is con - 
cerned, as that got by Brodie et alia (1946) who found 
only 20.8% of 48 Sonne cases bacteriologically positive 
after 31 gms. of the drug in 5 days but the number of 
cases is small in both series. Painton and Hantman 
(1945) treated 181. Sonno cases, 28 with sulphaguanidine, 
71 with succinyl sulphathiazole, 49 with phage and 33 
without any specific treatment. Succinyl sulphathiazole 
gave the best results with 1.5% of failures so far as 
bacteriological clearance was concerned; sulphaguanidine 
in doses of 8 gms. a day for 7 days gave one failure 
in 7 and in smaller doses of 4 gms. a day for 7 days 
it gave the same results as the phage- treated and 
untreated cases, namely 18 -24% of failures. The dose 
of/ 
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of succinyl sulphathiazole used was 0.25 gm. per kilo 
for 7 days. The number of cases treated with sulpha - 
guanidine was small and, even the bigger dosage used, 
was small but nevertheless, compared with the other 
methods of treatment, the results with succinyl sulpha- 
thiazole were by far the best. Several other American 
workers have published uncontrolled series of cases. 
Hardy, Burns and Decapito (194 :3) reviewed the treatment 
of 501 cases and carriers of Flexner, Sonne and Schmitz 
organisms with sulphaguanidine, succinyl sulphathiazole, 
sulphadiazine and sulphathiazole, and they concluded 
that all four drugs Controlled the symptoms and modifle 
the disease; they considered that sulphadiazene gave 
the best results and then succinyl sulphathiazole 
especially in Sonne carriers. Also Hardy and Watt(1944) 
in their review of 1,500 cases made up of Flexner, 
Sonne and other organisms, when ten different sulpho- 
nanides were used, considered that the poorly absorbed 
sulphonanides were no more successful than the others 
except that succinyl sulphathiazole was better for 
Sonne infections which were the most difficult to treat. 
Eisenhoff and Goldstein (1943) treated 33 Sonne cases 
and 50 carriers with 4 different sulphonanides, 
sulphathiazole, sulphadiazine, sulphagpanidine and 
succinyl sulphathiazole: 8 cases were positive after 
the course, 3 each after sulphathiazole and sulpha - 
guanidine and 2 after succinyl sulphathiazole: 2 of 
those/ 
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those failed to clear with a further course of sulpha - 
diazine, so once again it is seen that none of those 
drugs will clear all cases. Marshall et alla (1941) 
published good results in an uncontrolled series of 
dysentery cases treated with sulphaguanidine, and 
Barker (1943) studied the treatment of 5 dysentery 
carriers, 2 were Flexner infections and 3 alkalescens 
and they were treated with succinyl sulphathiazole. 
He concluded that a dosage of 0.1 gm. per kilo was 
inadequate but that 0.25 gm. per kilo was effective. 
Scott (1943) controlled an outbreak of Sonne dysentery 
in a home for mentally defective children with as 
little as 0.5 gm. t.i.d. of sulphapuanidine. 
CONCLUSIONS FROM THE AMERICAN WORK. 
American workers, therefore, have come to much 
the same conclusions as the British, and some of them 
were treating a more severe type of case. They found 
that sulphonamides gave results superior to the older 
methods of treatment, that Flexner infections were 
easier to treat, especially to clear bacteriologicall y, 
than Sonne infections; that sulphathiazole and sulpha - 
diazine probably gave as good results as sulphaguanidin 
and succinyl sulphathiazole, except in Sonne carriers 
where succinyl sulphathiazole proved more effective; 
and that some carriers were very resistant to any 
sulphonamide drug. There were two small series of 
cases / 
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cases, where controls were used, where no benefit was 
seen from the use of the drug; one where sulphathiazole 
was used to treat Sonne infections and one where 
phthalyl -sulphathiazole was used in Flexner, Sonne and 
Schmitz infections. Also no beneficial clinical effect 
was noted in a series of Boyd 88 infections when 
succinyl sulphathiazole was used and a comparison was 
made with untreated controls, but the convalescent 
carrier rate was much reduced. 
20. 
WORK DONE IN THE FORCES. 
Much of the bacillary dysentery which occurred in 
the forces and which was treated with sulphonamides 
was of the more severe Shiga type, but the results 
of treatment of some milder cases have also been 
published. Paulley (1942) studied the clinical results 
of the treatment of 173 cases, mostly Flexner in- 
fections, but some Sonne and Schmitz as well. He states 
that it had been concluded from a study of the treatment 
of dysentery in the Middle East that "do nothing and 
fluids was as good treatment at least as salines." 
He treated 60 cases with salines, the average period 
of stay in hospital being days; cases 
sulphaguanidine, the stay in hospital being 5.36 days; 
43 cases, and later another 30 got sulphapyridine, the 
stay in hospital being 4.26 and 4.96 days respectively; 
and 15 cases got kaolin, the stay in hospital being 
6.1 days. He concluded that sulphonamides gave results 
superior to the other methods and that sulphapyridine 
was better than sulphaguanidine. Scadding (1944) got 
equally good results in the treatment of 358 mild cases 
with sulphanilanide, sulphapyridine and sulphaguanidine 
the clinical results only were studied and the in- 
fections were Shiga, Sonne, Flexner and some unidenti- 
fied organisms but all were mild cases. Later Scadding 
(1945) treated 390 cases, 99 of whom were proved 
bacteriologically / 
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whom were Shiga infections, with sulphaguanidine. The 
found marked clinical improvement especially in severe 
cases and rapid healing of the intestine with reducti 
in toxaemia and a feeling of well- being. Only severe 
cases were treated and the best results were got in 
acute cases. Rutler and Marberg (1941) got good 
clinical results with sulphapyridine in the treatment of 
20 severe or moderately severe cases, mostly Flexner 
infections, in Haifa. They state that the stools were 
bacteriologically negative when found but do not give 
the standards of clearance employed. Bulmer and Priest 
(1942) claimed good results in an uncontrolled series 
of 77 cases treated with sulphaguanidine. Brewer (19.43) 
treated 77 severe cases, 26 were acute of whom six were 
Flexner infections, and 51 were chronic of whom fourteen 
were Flexner infections: they were given sulphaguanidine 
7 gm. and then 3.5 gms. 4 hourly till two days after 
II 
the stools were normal, and the chronic cases got 17.5 
gms. daily for 8 days, a dosage which he considered 
essential for such cases. The clinical results were 
good but treatment must be given until the bowel is 
healed; and the writer considered sigmoidoscopy 
essential in the chronic cases. No controls were used 
here but the results seem to have been striking in 
severe cases. Brewer (1944) also got good results 
with the use of succinyl sulphathiazole, 44 gms. in 5 
days, in the treatment of 16 Sonne cases which were 
still/ 
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still bacteriologically positive 1 -3 wks. after treat- 
ment: 9 of them had had sulphaguanidine for 5 days. 
15 of the cases were negative in 5 days and the other 
case was negative after a further course of the drug. 
3 -8 specimens or rectal swabs were examined 6 -20 days 
after treatment. The drug may, of course, have cut 
short the carrier state but, on the other hand, a big 
proportion of Sonne cases would be negative in that 
time without specific treatment. Osborn and Jones(1944) 
published the results of treating an outbreak of Sonne 
dysentery in a hotel being used as a Naval Officer's 
treatment establishment. They got better clinical 
results when they increased the dose from 18 mgm. in 
48 hrs. followed by 5 gms. daily to 30 gms. in 48 hrs. 
followed by 7.5 gms. daily but 8 out of 71 cases 
treated did not become negative. Ferriman and Mackenzi 
(1944), who used sulphaguanidine, sulphathiazole and 
sulphanilamide in the treatment of 56 cases of dysenter 
27 being proved bacteriologically, thought that sulpha - 
thiazole was more effective than sulphaguanidine and 
.should therefore be used in severe cases, while sulpha- 
guanidine, being less toxic, should be used in mild 
cases; sulphanilamide gave almost as good results as 
sulphaguanidine. Fairbrother (19.44) found that 10% 
of those with a recent history of diarrhoea were 




specimens from 2,500 Italian prisoners of war; and 
many carriers were probably missed as only one specimen 
was examined in many instances. The majority of those 
were t+'lexner infections and most of them cleared with 
one or at most two courses of sulphaguanidine. He 
found that 52% of cases of mild Sonne dysentery cleared 
bacteriologically in 2 weeks without sulphonamide 
treatment and, by 3 weeks, 60% of cases had cleared. 
The treatment of the remaining carriers with sulpha- 
guanidine (22 cases) and succinyl sulphathiazole (17 
cases) was not entirely satisfactory. The dosage of 
sulphaguanidine was 81 -90 gms. in 8 or 9 days and of 
succinyl sulphathiazole was 81 -90 gms. in 8 or 9 days, 
and the standard of clearance used was very high, 
namely 12 successive daily negative specimens taken 
some days after sulphonamide treatment had been stopped. 
CONCLUSIONS FROM THE WORK DONE IN THE FORCES. 
The most striking feature which is noticeable from 
reading the records of the use of sulphonamides in the 
treatment of bacillary dysentery in the forces, is the 
practically unanimous opinion that almost any of the 
sulphonamides modify the clinical course of the 
disease. Those who have used them in severe cases are 
most convinced of their value. The bacteriological 
results of treatment were not often studied but 
F'airbrother's results indicate that the carrier state 
is very common. 
25. 
4ENERAL CONCLUSIONS FROM THE LITERATURE REVIEWED ABOVE. 
1. Clinical effect of sul.honamides on bacillar 
dysentery. 
From a study of the published work on the subject 
there would seem to be no doubt about the fact that 
drugs of the sulphonamide group have some beneficial 
"effect on the clinical course of the disease. This 
conclusion has been arrived at by both British and 
American workers, although it is extremely difficult 
to demonstrate it in the mild type of case prevalent 
in this country and in parts of the United States; 
and it is the opinion held by those who have treated 
the much more severe type of the disease which occurs 
abroad. Although Scadding (1945) failed to demonstrat 
any significant difference on the course of the diseas 
when he compared cases treated with sulphaguanidine 
with controls treated with a chalk mixture, he points 
out that the cases were very mild, and that he thinks 
that severe and chronic cases benefited from sulpha - 
diazine. The only other workers quoted above who 
failed to demonstrate some beneficial clinical effect 
from the use of the sulphonamides were Roberts and 
Daniels (1943) who treated Boyd 88 infections with 
succinyl sulphathiazole, and Sandweiss (1944) who 
treated Flexner, Sonne and Schmitz infections with 
phthalyl sulphathiazole. They were working with small 
series/ 
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series of cases and it may be noted they were using 
poorly absorbed sulphonamides. They used control seri 
of cases. 
Although much of the work in all parts of the 
world was done without the use of controls, many of the 
workers had an extensive experience of the behaviour 
of the disease before the introduction of sulphonamide 
which lends some weight to their clinical impressions. 
2. Effect on convalescent carriers and discussion of 
standards of clearance. 
The effect of the drugs in reducing the number of 
cases which become convalescent carriers and in shorte 
ing the time during which they continue to carry the 
organism can only be judged by the study of strictly 
controlled series of cases; and there also arises the 
question of what can be considered adequate standards 
of bacteriological clearance. Fairbrother (1944), fro 
a study of Sonne carriers, considers that nothing short 
of 12 consecutive daily negative specimens or altern- 
atively 12 successive negatives over a period of at 
least 3 wks. would be adequate. He also emphasises 
that the specimens must not be examined for at least 6 
days after sulphonamide treatment has been stopped. 
This would mean that cases would be under observation 
for 3 wks. after treatment, an ideal which would not be 
easy/ 
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easy to attain in hospitals but which might well be 
used for a study of the different sulphonamides in, 
for example, outbreaks of the disease in asylums or 
other institutions. It also presupposes the avail- 
ability of the services of a first -class laboratory. 
gany workers, however, have used quite reasonable 
standards of clearance, for example consecutive 
negative bi- weekly specimens examined with the use of 
the modern highly selective media, and have demonstrate 
a definite reduction in the convalescent carrier rate 
in ±lexner and Newcastle infections, for example: 
Anderson and Cruikshank (1941) using suiphaguanidine; 
Clay (1943) using suiphaguanidine; Jamieson and others 
{1944) using suiphaguanidine, and Hardy and others(1942 
using suiphaguanidine. All those workers had control 
series of cases treated without sulphonamides. 
Some reduction in the number of convalescent 
carriers has also been got in Sonne infections by 
Swyer (19 4i) using suiphapyridine; Vollum and Wylie 
(1946) using succinyl sulphathiazole; Painton and 
Hantman (1945) using succinyl sulphathiazole; but other 
have failed to demonstrate any such reduction. in Sonne 
infections. Fairbrother (1944) using both sulpha - 
guanidine and succinyl sulphathiazole in Sonne cases, 
and Yannet and Leibovitz using sulphathiazole in Sonne 
cases both failed to get any reduction in the con- 
valescent carrier rate from the use of the drugs. 
Several/ 
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Several of the workers mentioned above have encountere 
resistant cases of both Flexner and Sonne infections 
which did not respond to repeated courses of sulphona- 
mides. 
:i. Effect on persistent carriers. 
There have been few adequate studies of persistent 
carriers, and it is here that it would be most difficul 
to demonstrate any effect, unless, of course, a drug 
were found which was effective in every case: no such 
drug has yet been found in any of the sulphonamides. 
There would, therefore, seem to be some evidence 
for the statement that, when used in the treatment of 
acute cases of bacillary dysentery, the sulphonamides 
have been shown to reduce the number of cases which 
become convalescent carriers; but the effect is not so 
noticeable if treatment is delayed, and the treatment 
of persistent carriers, especially Sonne carriers, is 
unsatisfactory. 
. Relative merits of the different sulphonamides. 
Concerning the relative merits of the different 
sulphonamides, good results have been got, both as 
regards clinical effect and bacteriological clearance, 
by the use of both the readily absorbed drugs and the 
less readily absorbed ones. In this country sulpha - 
guanidine has been the drug most used by those who 
have published their results, and it has proved 
satisfactory/ 
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satisfactory in Flexner infections; but Swyer (1943) 
got good results in a small series of Sonne infections 
with sulphapyridine, and Masefield (1941) likewise got 
good results in Flexner infections with sulphapyridine. 
Vollum and Wylie (1946) found succinyl sulphathiazole 
effective in Sonne cases and Brodie and others (194M) 
got better results, so far as bacteriological clearance 
is concerned, with phthalyl sulphathiazole in Sonne 
infections when they compared them with previous re- 
sults with sulphaquanidine. American workers have 
got good results with sulphadiazine but found succinyl 
sulphathiazole most effective in treating Sonne carriers. 
Some of the workers treating the disease in the forces 
have likewise got good results with absorbable sulphon- 
amides, for example Paulley (1942) with sulphapyridine, 
and Scadding (1944) with sulphapyridine and sulpha - 
nilamide; as well as with sulphaquanidine. 
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PART II. 
PERSONAL EXPERIENCE OF THE TREATMENT OF BACILLARY 
DYSENTERY WITH SULPHAGUANIDINE AND SUCCINYL 
SULPHATHIAZOLE. 
I. Between November 1943 and the end of 1945 there 
were admitted to the City Hospital, Edinburgh just over 
a thousand cases and carriers of bacillary dysentery 
from whom the dysentery bacillus was isolated; they 
constituted about half of the cases notified as suffer - 
ing from dysentery. 479 of these were Flexner in- 
fections, 87 were Newcastle and 506 Sonne infections. 
In 1943 and the first half of 1944 Flexner's 
bacillus was the predominant organism. Accordingly, it 
was decided to treat a series of Flexner infections 
with sulphaguanidine and, at the same time, to treat a 
control series with sodium sulphate. 
Method of procedure. 
Alternate admissions between Nov. 1943 and May 
1944 were given sulphaguanidine and sodium sulphate, 
and only those cases from whom the infecting organism 
was isolated are included in the series. Altogether 
143 casos were treated with sulphaguanidine and 142 
with sodium sulphate. 
Clinical/ 
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Clinical features of the cases. 
The cases were mostly very mild, usually having 
from a few days to a week of diarrhoea with blood and 
mucus in the stools, and accompanied by abdominal pain 
and general malaise. While a small percentage of the 
cases had a pyrexia of 102oó'. or over on admission, the 
majority had very little pyrexia and, in almost all of 
them, the temperature was normal after 24 hrs. in bed. 
A few of the admissions were more or less symptomless 
carriers detected on routine rectal swabbing of contact s, 
but most of those had a history of recent diarrhoea. 
There were two deaths in this group of cases; one, a 
man of 33 yrs. with Parkinson's disease and poor general. 
physique, died 7 days after admission from hypostatic 
pneumonia; the other, a man of 87 yrs., died 12 days 
after admission from myocardial degeneration. The first 
case had been treated with sulphaguanidine and the 
second with sodium sulphate, and both had recovered 
clinically from the attack of dysentery. They are not 
included in the series of cases as they were not 
bacteriologically negative at the time of death. 














































The dosage of sulphaguanidine was as follows: - 
TABLE II. 
0 -3 yrs 4 -10 yrs.11 -15 yrs Over 15 yrs. 
Initial dose 1 gm. 
then 
1.5 gms. 2gms. 3gms. 
1gm. 1gm. 






1.5 gms. 2 gms. 
4 hrly. 4 hrly. 
Total dosage 24 gins. 42.5 gms. 63.5 gms. 85 gms. 
This course lasted for 7 days. 
'Aperients, other than sodium sulphate, were given 
if' necessary during this course as sulphaguanidine was 
found to have a constipating. action. The 2 a.m. dose 
was omitted and half of it was added to the 10 p.m. and 
half/ 
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half to the 6 a.m. doses. The tablets were given 
rcrushed up and followed by a drink of milk or water. 
Ueneral management. 
The patients were put on to the above treatment on 
admission to hospital. They were given milk only while 
diarrhoea was severe, and then a light diet which was 
quickly increased to full diet as the condition 
improved. Abundant fluids were given by mouth, but 
none of those patients was sufficiently dehydrated to 
require the parenteral administration of fluid. Very 
little symptomatic treatment was required. 
Stool specimens or rectal swabs were taken and 
sent for examination on three successive mornings 
after admission, unless a positive specimen from the 
patient had been examined at the University Laboratory 
before admission to hospital. Stool specimens or 
rectal swabs were again taken on two, ors for patients 
returning to other hospitals or institutions, on three 
successive mornings beginning on the morning after the 
last day of treatment. Two successive negative specimen 
ors for those returning to hospitals or institutions, 
three successive negative specimens were required for 
discharge from hospital; and, of course, the patient 
had to be free of all symptoms. 
All the specimens were examined at the University 




desoxycholate- citrate medium was used. The vast 
majority of the cases were examined by ti-ie use of the 
rectal swab but, in some of the earlier cases, stool 
specimens were examined. 
In all of the cases here studied re- infection as 
a factor in some of the cases which continued to excret 
the organism for long periods cannot be eliminated, as 
the cases were not isolated separately. 
Likewise 7 of the cases in the above series were 
re- admitted at a later date, wither suffering from a 
clinical relapse or having been found to be bacterio- 
logically positive, but re- infection outside hospital 
could not be eliminated. Five of those cases had been 
treated with sulphaguanidine and two with sodium 
sulphate. 
Clinical results of treatment. 
The mild nature of the majority of the cases makes 
it difficult to measure the effect of the two methods 
of treatment on the clinical course of the disease. 
The number of days during which the patients were kept 
in hospital has been used by some for comparison of 
results, but this number was frequently determined by 
factors not related at all to clinical recovery. 
So many of the cases had only slight pyrexia, or none 
at all, that the effect of the drugs on pyrexia 
likewise could not be used. Adequate records of the 
presence/ 
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presence of blood and mucus in the stools were not kept 
owing to the difficulties of inspecting every specimen 
satisfactorily. The effect of the sulphaguanidine in 
producing a sense of well -being is difficult to measure, 
but was noticeable in the more severely ill cases and 
has been noted by many workers especially those treatin 
Very severe cases. The average number of days during 
tihich diarrhoea was present is a figure which can be 
sed as a measure of the effects of the two methods of 
treatment. Diarrhoea was judged to have stopped when 
the stools were formed and not more than two were 
passed in the 24 hrs. In the cases treated with sodium 
sulphate the average number of days during which 
diarrhoea was present was 3.4, while in the cases 
treated with sulphaguanidine the number was 1.7. 
This finding is similar to that of Clay (1943) who 
found that the number of days in hospital was halved 
in Flexner cases treated with sulphaguanidine compared 
with those treated with aperients. Also Jamieson and 
others (1944) found the average duration of symptoms 
6.4 days in cases treated with aperients and 4.8 days 
in sulphaguanidine- treated cases. On the other hand 
they found that cases treated with a chalk mixture 
had an average duration of symptoms of only 4 days, but 
the number of Flexner cases treated with the chalk 
mixture was very small (6). Scadding (1945) had 17 
Fl eane r/ 
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F lexner cases and 17 Flexner controls in the series of 
cases he treated with sulphaguanidine, the controls 
getting a chalk suspension, and he found no difference 
in the course of the disease with the two methods of 
treatment. Paulley (1942) found that the stay in 
hospital was 14.6 days in 60 cases treated with salines 
5.36 days in 25 cases treated with sulphaguanidine and 
6.1 days in 15 cases treated with kaolin. While, 
therefore, part of the effect of sulphaguanidine in 
reducing the average number of days of diarrhoea in 
the above series of cases may have been due to its 
constipating action, when the results are considered 
along with the findings of other workers, it would seem 
that sulphaguanidine reduces the length of time during 
which diarrhoea is present because of its effect on 
the cause of the intestinal infection. 
Bactariological results of treatment. 
The bacteriological findings following treatment 
































































































































































































































































































































































































































































































































































Discussion of those results. 
It is realised that the standard of clearance use 
in this series of cases is inadequate for two reasons: 
first of all two, or even three, negative cultures, 
even on a highly selective medium, taken on successive 
days immediately after treatment would not eliminate 
the possibility of att intermittent excretor of the 
organism, nor of the patient becoming positive again 
about a week after treatment; the second point for 
criticism is that the two or three specimens or rectal 
swabs were taken immediately after treatment had been 
stopped, without allowing time for the elimination of 
sulphaguanidine from the bowel. The actual number of 
cases after treatment was, therefore, 
probably higher than is shown, but some intermittent 
excretors would be missed in both series of cases, and 
the very big difference in the percentage of cases 
positive after the two different forms of treatment 
can hardly be accounted for by the presence of 
sulphaguanidine in the stools and nothing else. 
Furthermore, many of the third specimens taken on 
admission to hospital for diagnostic purposes, that 
is after 48 hrs. and often after 98 hrs. of sulphonamide 
treatment, gave positive results. It therefore seems 
that, in many cases, positive cultures can be got in 
the presence of considerable amounts of sulphonamide 
in the faeces. 
It/ 
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It will be seen from the above tables that the 
average number of days during which a positive culture 
was obtained in sulphaguanidine -treated cases was 8.1 
compared with 14.7 days for the cases treated with 
sodium sulphate. Also 17.6% of the sulphaguanidine - 
treated cases were positive after the course compared 
with 50.7% of the sodium sulphate- treated cases. 
At the end of 56 days 1 of the sulphaguanidine -treated 
cases was still positive compared with 3 which had 
been treated with sodium sulphate. 
Those results are similar to those of Clay (1943) 
who found that sulphaguanidine -treated Flexner cases 
were positive for an average of 6.6 days compared with 
13.3 days positive for cases treated with aperients. 
They may also be compared with the findings of 
Jamieson (1943) who found that 30% of Flexner cases 
treated with sulphaguanidine were positive in con - 
valescence compared with 50% of cases treated with 
sodium sulphate. He took the first specimen 4-6 days 
after clinical recovery and got three successive 
negatives at twice- weekly intervals. He was therefore 
taking specimens for a longer time after treatment 
which might account for the higher percentage of 
positives after sulphaguanidine. 
41. 
II. Ad the clinical results of treating Flexner 
dysentery with sulphaguanidine were better when com- 
pared with salts treatment, and, as the bacteriologica 
results were definitely better, at least with the 
standards of clearance used, it was decided to treat 
all cases of Flexner dysentery admitted after July 194 
with sulphaguanidine. It was also decided to see 
whether the giving of a further course of the drug in 
cases still positive after the course would result in 
a shortening of the carrier period. Accordingly, from 
July 1944 to the end of 1945, 194 cases of Flexner 
dysentery were treated with the same course of sulpha- 
guanidine and this was repeated once and more often if 
necessary until negative specimens were got. The 
second course was begun as soon as the positive report 
was received which was usually about four daps after 
the specimen had been sent. The cases were again mild 
and the procedure as regards the taking of specimens 
was the same as before. One of the cases, a girl aged 
6 yrs. was so ill and dehydrated on admission that she 
required an intravenous drip of glucose saline for 
24 hrs. She was also given 2 gms. of sulphadiazine 
in the drip before treatment with sulphaguanidine was 
begun. 
There was one death in this group of cases. 
It was in the case of a poorly nourished baby of -a yr 12 
who/ 
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who died 8 days after admission to hospital, and again 
it is not included in the results shown below as 
clearance tests had not been taken. 
The results of treatment are shown in the followin 
tables. - 
TABLE V. 
Age Oroup. 0-2 2 -5 5 -12 12 -60 Over All 
yrs. yrs. yrs. yrs. 60 yrs. Ages. 
No. of cases 66 31 24 40 33 194. 
Average No. 
of days 10.1 8.9 7.5 6.9 5.9 8.7 
positive. 
The number of cases still positive after one course of 
treatment was 27, that is 13.9%. 
They belonged to the following age -groups. 
TABLE VI. 
Age croup. 0 -2 2 -5 5 -12 12 -60 Over 
yrs. yrs. yrs. yrs. 60 yrs. 
No. of cases. 14 6 1 3 3 
Percentage 
of total No. 21.2 19.4 4.2 7.5 9.9 
in group. 
Two of those cases had three courses, their ages being 
1 12, and 17 yrs, and one case had four courses the 
age in that case being 120 
This case remained 
positive for 49 days. 
43. 
Discussion of those results. 
It will be seen that the average number of days 
during which the Flexner cases in this series remained 
positive was just about the same as before, 8.7 days 
compared with 8.1; while the percentage of cases still 
positive after the course was smaller, 13.9% compared 
with 17.6%. 
The giving of further courses of sulphaguanidine 
did not result in all cases becoming negative at once, 
as two cases required three courses of the drug and on 
four courses before negative specimens were got. Those 
findings seem to support the view held by many that 
the results of treatment in the acute stage of the 
disease are better bacteriologically as well as 
clinically than the results of treating later cases 
or convalescent carriers. This view has been expresse 
by Anderson and Cruikshank (1941); Jamieson and other 
(1944); Fairley and Boyd (1942 and 1943); Brewer (1943 
and Hall (1942) as well as by others. 
The giving of further courses of sulphaguanidine, 
as was done here, is really a study of the treatment 
of convalescent carriers similar to that of Fairbrothe 
(1944) and Brewer (1944) in the case of Sonne infectio s. 
In the series of cases here studied, however, the 
question of the development of drug resistance must 
be considered, as the cases were treated in the first 
instance/ 
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instance with suiphaguanidine. Although an acquired 
drug resistance has been described in the case of 
dysentery bacilli, M.R.C. War Memorandum No. 10 (1945) 
Fairbrother and Burner (1944) could find no evidence 
of it in a study of resistant Sonne cases. It would 
seem as if, after the acute stage of the disease has 
passed, and especially if the carrier state is prolong 
the organisms become in some way less accessible to 
the drugs. 
In the first series of cases described, numbering 
143, where no further course of suiphaguanidine was 
given, 25 cases were positive after the course of 
treatment, 7 after 28 days and 1 after 56 days; in the 
second series, numbering 294, where further courses of 
suiphaguanidine were given, 27 cases were positive 
after the first course, 6 after 28 days and 1 for 
49 days. There does not seem to have been any strikin 
effect from the repeated courses of the drug, but the 
numbers are too small to justify any definite con- 
clusion. 
The one case which was given an initial dose of 
sulphadiazine intravenously improved clinically very 
rapidly, buts of course, the parenteral administration 
of fluid to such cases often brings about rapid 
clinical improvement. This rapid clinical improvement 




sulphadiazine and sulphathiazole had been previously 
noted at the City Hospital in acute cases before the 
present investigation was begun, but only a few cases 
were so treated. 
III. Also in 1945, a series of 87 cases of Newcastle 
infection were similarly treated with repeated courses 
of sulphaguanidine if necessary. These cases were, on 
the whole, milder than the Flexner infections. 
The results of treatment are shown in the following 
tables. 
TABLE VII. 


























The number of cases still positive after one course 
of treatment was 8, that is 9.2%. They belonged to 




Age Groups 0 -2 2 -5 5 -12 
yrs. yrs. yrs. 
No. of cases 4 3 1 
Percentage of 
total in 10 
group. 
12 -60 Over 
yrs. 60 yrs. 
o o 
14.3 5.9 0 0 
Discussion. 
The bacteriological results of treatment in the 
Newcastle infections were better than in the Flexner 
cases but the cases were milder, and it must be noted 
that 9.2% of the cases were still positive after one 
course of treatment. 
IV. In 1944 Sonne dysentery began to appear among 
the admissions to the City Hospital as well as Flexner 
and, by 1945, it became very much moro prevalent than 
the Flexner type. 
In 1944 a series of 180 cases of Sonne dysentery 
was treated with sulphaguanidine, the procedure being 
exactly the same as for the Flexner infections treated 
with repeated courses of the drug. 
xs succinyl suiphathiazole became available it 
was decided to treat a series of cases of Sonne in- 
fection using this drug, but it was only used in those 
cases which, on admission, were known to be Sonne 
infections. In 1944 and 1945, 142 Sonne cases were 
therefore/ 
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therefore treated with succinyl sulphathiazole, in 
repeated courses where necessary, and in the same dose 
as sulphaguanidine. Another 184 Sonne cases admitted 
to hospital in 1945, but not diagnosed as Sonne in- 
fections before admission, were treated with a course 
of sulphaguanidine in the first instance but, if 
further courses were required, succinyl sulphathiazole 
was used. 
Clinically the cases were of a type very similar 
to the rlexner cases previously described. There was 
one death in a child of 4 yrs. in the series treated 
12 
with sulphaguanidine; one death in a thin poorly - 
nourished child of a- yrs. in the series treated with 
sulphaguanidine and succinyl sulphathiazole, and 3 
deaths in the series treated with succinyl sulpha - 
thiazole only. Two out of those three deaths were in 
children aged -i mths., one of whom died of pneumonia 
12 
and the other patient was aged 76 yrs. and died of 
hoart failure. The parenteral administration of fluid 
was required in three cases. 
The bacteriological results of treatment in the 




Age uroup . 0 -2 2 -5 5-12 12 -60 Over All 
yrs, yrs. yrs. yrs. 6011:1. ages. 
No. of cases 64 53 20 29 14 180 
Average No. 
of days 10.35 9.1 6.6 6.8 8.1 8.8 
positive. 
The number of cases still positive after one course 
of treatment was 38, that is 21.1%. 
They belonged to the following age -groups. 
TABLE X. 
Age uroup 0 -2 2 -5 5 -12 12 -60 Over 
yrs. yrs. yrs. yrs. 60 yrs. 
No. of cases 19 9 3 4 3 
Percentage of 
total No. 29.7 17 15 13.8 21.4 
in group. 
TABLE XI. 
Age uroup. 0 -2 2 -5 5 -12 12 -60 Over All 
yrs. yrs. yrs. _errs. awes. 
No. of cases. 63 48 18 38 17 184 
Average No. 
of days 13.2 9.9 9.8 6.4 4.9 9.4 
positive. 
The number of cases still positive after one course of 
treatment was 56, that is 30.4%. 




Age uaroup 0 -2 2 -5 5 -12 12 -60 Over 
yrs. yrs. yrs. yrs. 60 yrs. 
No. of cases. 32 13 7 3 1 
Percentage of 
total No. 50.8 27.1 38.8 7.9 5.9 
in group. 
TABLE XIII. 
Age iiroup 0 -2 2 -5 5 -12 12 -60 Over All 
yrs. yrs. yrs. yrs. 60 ,yrs. ages. 
No. of cases 51 28 8 45 10 142 
Average No. 
of days 9.6 8.2 6.8 5.9 6.8 7.8 
positive. 
The number of cases still positive after one course of 
treatment was 13, that is 9.4%. 
They belonged to the following age -groups. 
TABLE XIV. 
Age L*roup. 0 -2 2 -5 5 -12 12 -60 Over 
yrs. rs. rs. 61 rs. _yrs. 
No. of cases. 10 1 1 1 0 
Percentage of 





If the series of Sonne cases treated with sulpha_ 
guanidine is compared with the two series of Flexner 
cases similarly treated, it will be seen that, while 
the average number of days during which the cases re- 
mained positive was about the same, the percentage of 
cases remaining positive after one course of treatment 
is higher, namely 21.1% compared with 17.65 in the 
first J1 exner series and 13.9% in the second. The 
series of Sonne cases treated with sulphagzanidine 
first, and then with succinyl sulphathiazole may also 
be compared, when it is seen that the percentage of 
cases still'positive after the course of sulphaguanidine 
was as high as 30.4. 
On the other hand the Sonne cases which were 
treated entirely with succinyl sulphathiazole showed 
an average number of days positive of 7.8 and the 
percentage of cases positive after one course of the 
drug was only 9.4. All of those cases became negative 
after a second course of succinyl sulphathiazole but 
one of the cases was positive for 34 days altogether. 
In this series of cases it will be noted, there - 
fore, that the results of treating Sonne infections 
with succinyl sulphathiazole, certainly so far as 
bacteriological clearance is concerned, were very 
much better than the results when sulphaguanidine 
was/ 
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was used. This finding supports the view held in the 
United States, Hardy and Watt (1944), Painton and 
Hantman (1945), that succinyl sulphathiazole is the 
best drug for the treatment of Sonne infections but, 
on the other hand, Swyer (1945) found that the relapse 
rate was higher with succinyl sulphathiazole than with 
sulphanilyl benzamide and sulphanilylamidobenzamide. 
However he used a much smaller dose, 44 gms. in 5 days, 
and, with a drug whose action depends on a high con- 
centration in the large intestine, an adequate dosage 
for a sufficient length of time is essential. 
affect of age on the development of the carrier state. 
A point of importance which emerges from a study 
of the series of cases described above is the fact 
that, in 5 out of the 7 series of cases, the 0 -2 age - 
group was the one in which the biggest percentage of 
cases remained positive after a course of treatment; 
while, again in 5 out of the 7 series, the 12 -60 age - 
group was the one in which the smallest percentage of 
cases remained positive after treatment. This applies 
to the first series treated with sodium sulphate as 
well as to the series treated with sulphonamide, so 
it has nothing to do with the response to sulphonamide 
at the different age- groups. It means that, before 
assessing the results of treatment in bacillary 
dysentery/ 
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dysentery with any drug, the age -group to which the 
patients belonged must be known, asp judging by the 
experience of the 1000 cases just described, the 
bacteriological results will be much better in adults 
than in children, especially children under 2 yrs. 
Blood levels of sulphaguanidine and succinyl 
sulphathiazole. 
(1) Sulphaguanidine. 
In 60 of the cases in the first series treated 
with sulphaguanidine estimations of the level of "free" 
sulphaguanidine in the blood were made. Altogether 
110 such estimations were carried out, some of the 
patients having blood removed for examination on two 
or three occasions. The first specimen was not taken 
until 24 -36 hrs. of treatment had been carried out, 
and no specimens were taken later than the last day of 
treatment. Owing to the difficulties of getting blood 
from young children only adults or older children were 
used for this purpose. 
The "free" sulphaguanidine in the blood was 
estimated by me at the City Hospital using the method 
of Bratton and Marshall and a Lovibond Comparator. 
Results. 
The average blood level of "free" sulphaguanidine 
in/ 
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in the 110 estimations was 1.9 mgms. per 100 c.c. 
The highest level was 6 mgms. per 100 c.c.s i case 
had a level of 4.5 mgms, 3 a level of 4 mgms, 1 a level 
of 3.5 mgms. and 4 a level Of 3 mgms. 
The remaining 100 specimens had a blood level of 
under 3 mgms, the lowest amount being a "trace" got on 
5 occasions. 
The blood level in any one patient tended to 
remain about the same throughout the course of treatment. 
An interesting finding was that, although only 
26 out of the 60 patients examined were over 60 yrs. 
of age, all of the ten patients who had blood levels of 
3 mgms. or higher were over 60 yrs. of age, 7 of them 
being over 70 yrs. of age. 
Similar results were got in ..a, further 96 estima- 
tions carried out on patients receiving the same 
course of sulphaguanidine and suffering from "clinical 
dysentery" but not included in the series under dis- 
cussion as the infecting organism was never isolated. 
One of these patients, a man of 74 yrs. had a blood 
sulphaguanidine level of 7.5 mgms. and another six 
patients, all over 60 yrs. of age, had blood levels 
over 3 mgms. per 100 c.c. Less than half of the 
patients belonged to the over 60 age -group. The 
average blood -level in this group of cases was 1.7 mgms. 




The findings described above may be compared with 
those of Hay (1943) who found that blood- levels of 
sulphaguanidine varied from 3 mgms. per 100 c.c. to a 
"trace ". He found a concentration of 9 mgms. on one 
occasion, 8 mgms. on two occasions, 7 mgms. on one 
occasion and g mgms. on one occasion. He was using 
a slightly smaller dosage of the drug and does not 
give the ages of the patients examined. 
Jamieson and others (1944) remark that, in spite 
of claims that sulphaguanidine is poorly absorbed from 
the bowel, surprisingly high concentrations are found 
in the urine, and, of course, that is evidence of 
absorption into the blood. 
As already noted, Smith (1944) got blood levels of 
10-14 mgms. per 100 c.c. after 24 gms. of the drug 
daily for 2 days and he found that the blood -levels 
fell as the daily dosage was reduced. 
It is therefore evident that, while sulphaguanidi 
does not reach as high blood- levels for the dosage 
given as the more readily absorbed drugs, it may, on 
occasion, reach quite high levels even with the 
ordinarily used dosage. It may therefore exercise 
part of its effect through the blood stream, and also 
toxic effects arising from its presence in the blood 
and from its excretion by the kidneys might be expecte 
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No reference in the literature has been found to 
the fact that relatively high blood -levels of the drug 
are more likely to occur in old people, but the findin s 
recorded above indicate that special care may be neces1 
nary in such cases to ensure an adequate fluid intake. 
The high levels may be due to a greater absorption from 
the bowel in old people, or they may be due to a slower 
excretion of the drug or to a slower acetylation in 
such cases. The total amount of sulphaguanidine in the 
blood was not estimated so the amount of acetylated 
drug present in those cases is not known. 
(2) Succinyl sulphathiazole. 
22 samples of blood from 11 of the patients 
treated with succinyl sulphathiazole were examined but 
only a trace of the drug was found, indeed, on two 
occasions, none at all could, be demonstrated. This is 
in agreement with the findings of others who have foun 
that only traces of this sulphonamide are absorbed. 
Toxin/ 
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Toxic effects of sul ha, uanidine and succinyl 
suiphathiazole. 
(1) Sulphag uanidine. 
The only toxic effects observed in the whole 
of the cases treated with this drug were a drug rash, 
seen on two occasions, and a drug fever seen once. 
The rashes appeared at the end of one course of the 
drug and were morbilliform in type, being present on 
the arms and legs with a few indefinite spots on the 
trunk. The patients developing them were aged 6 yrs. 
and 54 yrs. The patient who developed the drug fever 
was aged 35 yrs., and had a temperature of 101 -102 °F 
for two days after the course of sulphaguanidine. 
No other cause for the pyrexia could be found. Blood 
sulphaguanidine levels were not estimated in these 
oases but Smith (1944), who got a high percentage of 
rashes in his cases treated with big doses of the drug, 
found no relation between the blood sulphaguanidine - 
level and the development of a rash. None of the 
patients in this group who developed a rash or drug 
fever had been previously treated with any sulphonamide. 
(2) Succinyl sulphathiazole. 
A few of the adult patients treated with this 
drug complained of some abdominal discomfort, and ther 




Apart from this no toxic effects of any kind were 
observed. 
Comment. 
In the group of cases under consideration both 
sulphaguanidine and succinyl sulphathiazole, even in 
repeated courses, proved to be remarkably free from 
the risk of toxic side -effects. 
Summary. 
1. Sulphaguanidine gave clinical results slightly 
superior to sodium sulphate when used in the treat- 
ment of 285 cases and carriers of Flexner dysentery. 
The average number of days during which diarrhoea 
was present in the sulphaguanidine -treated cases 
was 1.7, while in the sodium sulphate- treated cases 
it was 3.4. 
2. After a course of treatment fewer cases in the 
sulphaguanidine series were bacteriologically 
positive. The percentages in this first series 
of cases were 17.6 for the sulphaguanidine -treated 
cases and 53.3 for the sodium sulphate- treated 
cases. The average number of days during which 
those treated with sulphaguanidine remained positive 
was 8.1 and, for those treated with sodium sulphate, 
it/ 
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it was 14.7. In a further group of 194 Flexner 
infections treated with sulphaguanidine in repeate 
courses if necessary the percentage of cases still 
positive after the first course was 13.9, and the 
average number of days during which the cases 
remained positive was 8.7. 
3. In a small group of 87 Newcastle infections 
similarly treated the percentage of cases still 
positive after one course of sulphaguanidine was 
9.2, and the average.number of days during which 
the cases remained positive was 6.8. 
4. In the treatment of Sonne infections succinyl 
sulphathiazole gave results superior to sulpha- 
guanidine so far as bacteriological clearance was 
concerned. In 142 cases and carriers of Sonne 
infection treated with succinyl sulphathiazole, in 
repeated courses if necessary, only 9.4 was 
positive at the end of one course of treatment, 
while in 180 Sonne infections treated with sulpha- 
guanidine 21.1% was positive after one course and, 
out of another 184 Sonne infections, :30.4% was still 
positive after one course of sulphaguanidine. The 
average number of days during which the cases in 
the first series remained positive was 7.5, in the 
second series it was 8.8 and in the third it was 
9.4. The third series had a first course of 
sulphaguanidine followed, if necessary, by courses 
of/ 
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of succinyl sulphathiazole. No control series was 
treated with sodium sulphate in the case of Sonne 
infections. 
5. In 5 out of 7 of the series of cases studied it 
was noted that the age -group 0 -2 yrs. gave the 
biggest percentage of cases still positive after 
a course of treatment. The age -group giving the 
lowest percentage of positive cases after a course 
of treatment was, in 5 out of the 7 series, the 
12 -60 one. This difference in the bacteriological 
results of treatment in the different age- groups 
was present in the cases treated with sodium 
sulphate as well as in those treated with 
sulphonamides. 
6. The average blood level of "free" sulphaguanidine 
got with the dosage used was 1.9 mgms. per 100 c.c. 
In 10 out of 110 blood samples examined the amount 
was 3 mgms or more, the highest amount being 6 mgms. 
per 100 c.c. These high readings were all got in 
patients over 60 yrs. of age. 
Only a trace of succinyl sulphathiazole was 
detected in 22 specimens of blood examined. 
Sulphaguanidine and especially succinyl 
sulphathiazole were both very free from toxic side - 
effects even when given in repeated courses amounting 
in a few cases to a total amount of 340 gms. 
OU. 
Conclusions. 
The results described above are therefore a 
further demonstration of the value of, and also of the 
limitations of, sulphaguanidine and succinyl sulpha - 
thiazole in the treatment of bacillary dysentery. 
While showing that sulphaguanidine gives results 
superior to sodium sulphate in the treatment of Flexner 
dysentery, they show that, certainly in this instance, 
it was not nearly as effective in bringing about 
bacteriological cure in Sonne infections. Succinyl 
sulphathiazole was much more effective in this respect. 
Also, whatever may be the short -comings of the 
standard of clearance adopted, one thing of importance 
was demonstrated: at least 10% of Sonne infections 
treated with succinyl sulphathiazole, and at least 
about 18,5 of Flexner infections treated with sulpha- 
guanidine still gave positive cultures after a course 
of treatment. 
The importance of two factors which must be taken 
into account when the results of the use of sulphonamide 
drugs in the treatment of this disease are being con- 
sidered, was brought out namely, the type of the in- 
fecting organism and the age of the patient. 
It was again demonstrated, as had been shown by 
previous workers, that repeated courses of the drugs 
were sometimes necessary to effect bacteriological cure, 
and that, even in repeated courses, sulphaguanidine 
and 
especially succinyl sulphathiazole are very free from 
the risk of toxic effects. 
61. 
PART III. 
DISCUSSION AND RACOMMENDATIONS FOR TREATMENT. 
From a consideration of the published work 
described above, and from personal experience of 
treating the 1000 cases just recorded, it can be 
concluded that all cases of bacillary dysentery - 
by which is meant all cases of infection with dysentery 
bacilli, whether they have blood and mucus in the 
stools or not - should be treated, as soon as possible, 
and as thoroughly as possible, with a sulphonamide 
drug, partly because of its effect on the clinical 
course of the disease, but mainly because of its effect 
in reducing the number of cases bacteriologically 
positive after treatment. In this country the latter 
effect is of much more importance than the clinical 
effect in the majority of cases. 
Choice of sulphonamide. 
It has to be decided which of the available 
sulphonamides should be used. There are available for 
use in intestinal infections two main groups of 
the 
drugs: those, such as sulphanilamide, sulphapyridine, 
sulphathiazole, suiphadiazine and sulphamerazine 
which 
are almost completely absorbed before 
the large 




incompletely absorbed such as sulphaguanidine, or 
hardly absorbed at all such as succinyl sulphathiazole 
and phthalyl sulphathiazole. There are also the more 
recently introduced su.lphanil lbenz ide and 
su.lphanil ylamidobenzamide which are incompletely 
absorbed. A majority of workers has concluded that 
there is no qualitative difference between the dif- 
ferent sulphonamides - with the exception of rarphanil - 
but that the different clinical effects of the drugs 
are dui to such factors as differing solubility, rate 
of absorption and excretion, degree of ionisation etc. 
(11.:x. C. war memorandum No.10. 1945) . The problem is 
therefore to decide by which method an a eu..t.e concen- 
tration of active sulphonamide can be _c, in ,c nts t 
with the organisms. The great a . , - ze of the 
absorbe drus , s that :he. ;:.-17.e. rise to _ ' . 
affects tha.". the others. ... .he other han t_. 
to b<= given in lari-1 er doses than h. more re ,` ? -z 
at :>o J e _ ^ .., 
s 
a.:..`1 au34haguantfna at least is a 
elativei. c. b,acter iostatic _ . :n o_^ 
... 7 J iu.. Tr.rj th ;-°r drug giving, ahigh .. l,;7 1 
._ _lpn c:.aL i _ , is requ.ired, or one which 
ab sorbed. sald there_o.^,e reaches a blet . . . _ 1.^ a ? ion 
... towel, som= asp -cts of the _ a,.__._ of th. 
... . ,. ._ a . i be considered. 
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Pathology. 
Although bacillary dysentery, in all but the most 
severe cases, is a local disease of the large intestine 
and occasionally of the terminal part of the small 
intestine, the general disturbance being due mainly to 
toxaemia, Manson -Bahr (1942) states that dysentery 
bacilli can be seen in sections of the intestine in 
the muscularis mucosae and especially in the solitary 
follicles. Bacilli have been recovered in severe cases 
from the joint effusions in cases of arthritis. Even 
if it is conceded that, in the ordinary case, the 
bacilli do not penetrate deeply into the mucous membrane 
and enter the blood stream in great numbers, it seems 
reasonable to suppose that they do penetrate a little, 
and, the more acute the disease, the greater will be 
the number of organisms which have entered the tissues. 
Also, in chronic cases, granulations and chronic ulcer 
develop and the mucous membrane may undergo cystic 
degeneration, the organisms persisting in the mucous 
secretion of retention cysts in the bowel wall (Manson 
Bahr, 1942). 
In view of the pathology described above one would 
expect that the best results in the acute stage of the 
disease, and especially in severe cases where organisms 
are penetrating the tissues, should be got with 
sulphonamides reaching a high concentration in the 
blood. That would also seem to be a reasonable method 
f/ 
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of getting the drug into contact with organisms at the 
bases of ulcers, provided too much fibrous tissue has 
not formed to wall them off. On the other hand, once 
the acute infection has subsided and the organisms may 
be' as suggested by Fairbrother (1944) in the case of 
bonne infections, leading a more saprophytic existence 
in the bowel lumen, then an active sulphonamide in 
high concentration in the large intestine, that is one 
which is poorly absorbed, should give the best results, 
certainly so far as bacteriological clearance is con- 
cerned. It would also be expected that, in some cases, 
where the bacilli are buried in fibrous tissue or in 
granulations or are deep down in thick -walled cysts, 
neither sulphonamide in the blood stream or sulphon- 
amide in the lumen of the intestine would reach the 
organisms. 
Sulphonamide -sensitivity of the organism. 
The other theoretical consideration when deciding 
which sulphonamide will be most effective, is the 
sensitivity to sulphonamide of the different types of 
dysentery bacilli. 
itarshall and others (1940) claimed that sulpha- 
guanidine was inhibitory, bacteriostatic and bacteri- 
cidal in vitro for organisms of the dysentery group. 
Brewer (1944) found that Sonne strains were inhibited 
by succinyl sulphathiazole but that sulphag uanidine was 
relatively ineffective. This result was confirmed by 
Fairbrother/ 
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Fairbrother (1944) who found that Flexner organisms 
gave the same results. Jamieson and others (1944) 
found that sulphaguanidine was bacteriostatic but not 
markedly so for a blexner strain, Sonne III and Shiga 
organisms. Brodie and others (1946) demonstrated that 
phthalyl sulphathiazole had a bacteriostatic effect on 
Flexner, Sonne III and Newcastle organisms which was 
more pronounced when a semi -solid medium was used; and 
Poth and Ross (1944) had shown that phthalyl sulpha- 
thiazole had twice the bacteriostatic effect of 
succinyl sulphathiazole on coliform organisms. It 
therefore appears that in vitro, sulphaguanidine is 
not as active against dysentery bacilli as succinyl 
sulphathiazole and that this is most marked when the 
Sonne bacillus is used, as the Flexner organism respond 
to the less active drug. Phthalyl sulphathiazole 
appears to be still more active. 
From those laboratory findings one would expect 
succinyl sulphathiazole and phthalyl sulphathiazole to 
be more effective than sulphaguanidine under those 
circumstances discussed above where a poorly absorbed 
sulphonamide is required. 
Clinical findings. 
In fact, a good deal of support for the conclusions 
arrived at from a consideration of the pathology and 
bacteriology of the disease is got from the published 
results/ 
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results of the clinical use of the drugs. It has been 
found that the readily absorbed sulphonamides have 
usually given results as good as, and in some cases 
better than, the less readily absorbed drugs, in the 
clinical cure of the disease, and especially in the 
treatment of severe cases. This has been found in this 
country, in the United States and by those treating 
cases in the forces. The best bacteriological results, 
on the other hand, following treatment of the more 
resistant Sonne type of organism have been got with 
poorly absorbed drugs such as succinyl sulphathiazole. 
Also, even with the use of this drug in big doses, 
there is still a percentage of failures. 
Dosage of sulphonamides. 
So far as dosage of the drugs in this disease is 
concerned, a relatively small dose of the readily 
absorbed sulphonamides has proved adequate; in the 
case of sulphadiazine, Scadding (1945) found 3 gm. 
daily sufficient in mild cases. As sulphadiazine is 
very slowly excreted an adequate blood -level of the 
drug can be maintained with three or four doses given 
during the day. The small dosage has some advantage 
where large numbers are being treated and where infants 
and young children are concerned. In very severe cases 
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The poorly absorbed drugs at present in use re- 
quire to be given in bigger doses so as to saturate the 
contents of the gut. The good results in Sonne in- 
fections got at the City Hospital with succinyl suipha- 
thiazole were got with a dosage of 12 gms. a day for 
7 days. As this drug is hardly absorbed at all no 
general toxic effects are likely to arise with big 
doses and the bìg doses are more likely to result in 
the drug reaching all parts of the folded mucous 
membrane of the bowel. Where sulphaguanidine is con - 
cerned, although toxic effects are few and unimportant, 
they do occur, as demonstrated by Smith (1944) and 
Brewer (1943) if big doses are given; and indeed, in 
sensitive with doses 1944). 
At least 12 gms. a day, which was the dosage employed 
at the City Hospital where negligible tootle effects 
were got, is probably required and some workers, for 
example Brewer (1943) recommend bigger doses in chronic 
cases. There would seem to be no need for giving the 
drug more than four times daily, and it seems reasonable 
to give a larger dose in the first 24 hrs. to attempt 
to saturate the bowel contents as soon as possible. 
The big doses of the poorly absorbed drugs which are 
required are a disadvantage where big numbers have to 
be treated and also where children are concerned. 
The duration of treatment required will depend on 
the severity of the disease but probably a minimum 
of/ 
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of 5 days treatment is necessary even in mild cases, 
and 8 to 10 days treatment at a time is required to 
get the bast results in chronic cases and carriers. 
It has been shown at the City Hospital, and also by 
others, that repeated courses of the less readily 
absorbed drugs can be given without toxic effects. 
Recommendations for treatment. 
It is therefore recommended that acute cases of 
bacillary dysentery be treated witri one of the readily 
absorbed sulphonamides in doses of 4 to 6 or more 
grammes daily depending on the severity of the disease. 
This should be continued until the acute stage is 
passed as judged by the disappearance of pyrexia and 
of blood and mucus from the stools, and by the stools 
becoming less frequent and formed. As sulphanilamide 
and sulphapyridine are more liable to give undesirable 
toxic effects and, as good results have been got with 
sulphathiazole and sulphadiazine, the latter would 
seem to be the drugs of choice. Although no published 
work has been found on the results of the use of 
sulphamerazine, on theoretical grounds it should prove 
satisfactory. It is submitted that, in cases endanger- 
ing life, the toxic effects from the use of those.drugs 
are no bar whatever to their use, if it has been shown 
that they act more quickly in such cases and have a 
more marked effect on the course of the disease. 
Likewise,/ 
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Likewise, in all really acute cases, the benefits of 
the drugs seem to outweigh any disadvantages. It is 
suggested that, after the acute stage of the disease 
is passed - and this applies especially to Sonne 
infections - full doses of the most active poorly absorbed 
sulphonamide be given for a period of at least 5 days. 
At present succinyl sulphathiazole appears to be the 
most active of those drugs, but phthalyl sulphathiazole 
may prove more active in big doses. 
Sulphaguanidine, although it is not as active in 
dealing with organisms in the bowel as succinyl sulpha- 
thiazole' and, although it does not act as quickly on 
the acute symptoms as the readily absorbed drugs, does 
seem to combine the two effects to a certain extent; 
and it gives fewer toxic effects than the readily 
absorbed drugs. It does, therefore, seem to have a 
sphere of usefulness in treating mild infections with 
b'lexner or Newcastle types of organism, where toxic 
effects are undesirable. Nevertheless it is just in 
that type of case that resistant infections are likely 
to arise and more active drugs may have to be resorted 
to. Of course, in all severe cases, abundant fluids 
must be given, parenterally if necessary, especially 
if sulphonamide drugs which may cause blockage of renal 
tubules are being used. The diet need not be unduly 
restricted in mild cases, but should be light as long 
as diarrhoea is present. 
Although/ 
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Although it is hoped that by the above active 
measures in acute cases, the number of cases bacterio- 
logically positive after treatment will be reduced, it 
is obvious, from recorded clinical experience, that a 
percentage of cases will remain positive after the 
course of treatment outlined above. There also remain 
for consideration the contact carrier and the case 
which comes under observation only when the convalescern 
carrier state is established. It is suggested that, 
in all of those cases, a few days treatment should be 
given with a readily absorbed sulphonamide which will 
reach any organisms accessible from the blood stream; 
after that full doses of succinyl sulphathiazole, or 
of any more active poorly absorbed drug which may be- 
come available, should be given for a period depending 
on the length of time for which the carrier state has 
been known to exist. A course of 14 days or repeated 
courses may be necessary if the carrier state is of 
long standing. It is also suggested that, before 
treatment with a poorly absorbed sulphonamide is 
begun, the bowel should be emptied, as far as possible, 
by two or three doses of sodium sulphate in the 24 hrs. 
preceding treatment; and that diet during the course 
should be very light so as to reduce the amount of 
residue in the large intestine, and so allow a greater 
chance of the drug reaching the whole surface of the 




receiving long courses of poorly absorbed sulphonamides 
that owing to destruction of bacilli which are normal 
inhabitants of the bowel, vitamin synthesis may be 
interfered with. An adequate supply, especially of 
the vitamin B. group should therefore be ensured. 
In cases which remain positive in spite of a 
course such as this it may be worth while having the 
organism tested for sulphonamide sensitivity, as it 
may be a sulphonamide resistant strain or it may have 
acquired resistance to sulphonamides. 
The treatment of the more severe type of case due 
to infection with the Shiga bacillus, which is rarely 
seen in this country, is not really being considered 
in this combined serum treatment, 
sulphonamides have apparently proved effective in such 
cases. Those who have experience of the treatment of 
the chronic type of case advise sigmoidoscopy to find 
out the condition of the bowel mucous membrane, and 
prolonged treatment with sulphonamides until healing 
has taken place. It would therefore seem advisable, in 
really persistent carriers in this country, to carry 
out sigmoidoscopic examination to find whether there 
is any lesion of the mucous membrane which is the 
cause of the carrier state. 
In conclusion it may be stated that, while the 
use of drugs of the sulphonamide group in the treatment 
of bacillary dysentery is a definite advance in the 
therapy/ 
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therapy of that disease, it is still not possible to 
effect bacteriological cure of the disease in every 
case. The best results obtainable at present can only 
be got by a study of the individual requirements of 
each case and by the use of both the readily absorbed 
sulphonamides and those which are poorly absorbed 
and therefore reach a high concentration in the large 
bowel. Further advances in therapy await the intro- 
duction of a drug more active against dysentery bacilli, 
and also a better understanding of the reasons for 
the development of dysentery carriers. 
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